ImmunoPrecise Antibodies Revenue and Competitors
Estimated Revenue & Valuation
- ImmunoPrecise Antibodies's estimated annual revenue is currently $16.6M per year.
- ImmunoPrecise Antibodies's estimated revenue per employee is $155,000
Employee Data
- ImmunoPrecise Antibodies has 107 Employees.
- ImmunoPrecise Antibodies grew their employee count by 11% last year.
ImmunoPrecise Antibodies's People
Name | Title | Email/Phone |
---|---|---|
1 | Controller | Reveal Email/Phone |
2 | VP Commercial Services | Reveal Email/Phone |
3 | Head Protein production, Scientist | Reveal Email/Phone |
4 | Director Business Development | Reveal Email/Phone |
5 | Creative Director | Reveal Email/Phone |
6 | Scientific Director | Reveal Email/Phone |
7 | Director Client Relations | Reveal Email/Phone |
8 | Director Client Relations | Reveal Email/Phone |
9 | Director Client Relations / Quality Manager | Reveal Email/Phone |
10 | Animal Care Program Manager | Reveal Email/Phone |
ImmunoPrecise Antibodies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.7M | 127 | -5% | $132.7M | N/A |
#2 | $8.8M | 57 | -7% | $2M | N/A |
#3 | $12.9M | 83 | 5% | N/A | N/A |
#4 | $10.2M | 66 | 8% | N/A | N/A |
#5 | $101.6M | 468 | -11% | $94.5M | N/A |
#6 | $22.5M | 262 | 0% | $845.8M | N/A |
#7 | $9.8M | 34 | -68% | $494.1M | N/A |
#8 | $443.8M | 673 | 11% | $371.2M | N/A |
#9 | $27.6M | 178 | 19% | N/A | N/A |
#10 | $82M | 378 | 8% | $871.5M | N/A |
What Is ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies is a global company highly specialized customer focused life sciences company that provides custom antibody development and immunology services.\n\nOur dedication to advancing antibody development has resulted in cutting-edge immunological innovations such as single-step cloning, Rapid Prime immunization strategies, and recombinant monoclonal technology. \n\nWe pride ourselves on our high customer satisfaction and our clients have grown accustomed to receiving thorough and professional service. We customize your project to generate antibodies that meet your specific needs. Over our 20+ year history, we have gained the trust of a diverse group of customers that include research agencies, universities, biotechnology and pharmaceutical companies of all sizes from around the globe.\n\nImmunoPrecise is pleased to announce its newest line of services, ImmunoProtectâ„¢. With ImmunoProtectâ„¢, the DNA sequence of your mAb is determined and can be used to express your antibody recombinantly. Determining your monoclonal antibody DNA sequence not only provides valuable information about your clone but preserves the information forever. This is critical for unstable and poorly secreting hybridomas and also required for patent applications, antibody engineering and cell line validation.\n\nWe would be happy to discuss your antibody needs, please contact us or visit our website for more information.
keywords:N/AN/A
Total Funding
107
Number of Employees
$16.6M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ImmunoPrecise Antibodies News
For the month of April, 2022. Commission File Number: 001-39530. ImmunoPrecise Antibodies Ltd. (Exact Name of Registrant as Specified in Charter)
ImmunoPrecise Antibodies (NASDAQ:IPA) said its antibody cocktail PolyTope TATX-03 showed strong neutralizing activity against Omicron...
Insider Buying: ImmunoPrecise Antibodies Ltd (TSE:IPA) Senior Officer Acquires C$74,875.00 in Stock. Posted by admin on Apr 12th, 2022.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $19.6M | 109 | 11% | N/A |
#2 | $32.5M | 112 | 9% | N/A |
#3 | $16.2M | 112 | 5% | N/A |
#4 | $28.3M | 113 | N/A | N/A |
#5 | $25.5M | 116 | 8% | N/A |